PUMA BIOTECHNOLOGY, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.17 USD | -4.58% |
|
-15.59% | -3.70% |
| 05-17 | Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial | RE |
| 05-02 | Transcript : Puma Biotechnology, Inc., Q1 2024 Earnings Call, May 02, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 201M | - | - | ||||
| 55.07B | - | |||||
| 40.22B | ||||||
| 41.79B | ||||||
| 28.17B | ||||||
| 26.28B |
